Lipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC).

A recent study highlights vitamin D's crucial role in colorectal cancer prevention, noting that deficiency is linked to ...

Vascular endothelial growth factor inhibitors (VEGFIs) have transformed treatment paradigms for several malignancies. By ...

Evidence-based, peer-reviewed studies have shown that a single dose of HA after a procedure accelerates tissue healing, ...

A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...

Biocon's share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company's seventh USFDA ...

Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar ...

Biocon Biologics, a subsidiary of Biocon Ltd, announced on Thursday that it has received approval from the United States Food ...

Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global ...

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...

Hydrogels, which are soft materials formed by cross-linking polymers, could have a variety of medical applications. In ...

Download this technical note to explore how a qualitative, real-time, high-throughput in vitro tube formation assay helps ...